A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacokinetics, and pharmacodynamics
of multiple ascending doses of VX-708 in healthy participants